Others titles
- Antimicrobial Use and Resistance Eligible Bacteria Antibiotic Agents
- Antimicrobial Resistance Research Use and Resistance Eligible Antimicrobial Agents
Keywords
- Bacteria Antibiotics
- Antimicrobial Resistance Research
- Bacteria Antibiotics
- Antimicrobial Resistance Research
- Antimicrobial Use
- Antimicrobial Resistant Infections
Antimicrobial Use and Resistance Eligible Antimicrobial Agents

The National Healthcare Safety Network (NHSN) Antimicrobial Use and Resistance (AUR) provides a mechanism for facilities to report and analyze antimicrobial use and/or resistance as part of local or regional efforts to reduce antimicrobial resistant infections through antimicrobial stewardship efforts or interruption of transmission of resistant pathogens at their facility.
Get The Data
- Research
Non-Commercial,
Share-Alike,
Attribution Free Forever
- Commercial
Commercial Use,
Remix & Adapt,
White Label Log in to download
Description
The primary objective of the Antimicrobial Use option is to facilitate risk-adjusted inter- and intra-facility benchmarking of antimicrobial usage. A secondary objective is to evaluate trends of antimicrobial usage over time at the facility and national levels.
This module contains two options, one focused on antimicrobial usage and the second on antimicrobial resistance. To participate in either option, facility personnel responsible for reporting antimicrobial use (AU) or resistance (AR) data to the National Healthcare Safety Network (NHSN) must coordinate with their laboratory and/or pharmacy information software providers to configure their system to enable the generation of standard formatted file(s) to be imported into NHSN. The format provided for data submission follows the Health Level (HL7) Clinical Document Architecture (CDA).
About this Dataset
Data Info
Date Created | 2014-01-01 |
---|---|
Last Modified | 2022-03-01 |
Version | 2022-03-01 |
Update Frequency |
Irregular |
Temporal Coverage |
N/A |
Spatial Coverage |
United States |
Source | John Snow Labs; Centres for Disease Control and Prevention; |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Bacteria Antibiotics, Antimicrobial Resistance Research, Bacteria Antibiotics, Antimicrobial Resistance Research, Antimicrobial Use, Antimicrobial Resistant Infections |
Other Titles | Antimicrobial Use and Resistance Eligible Bacteria Antibiotic Agents, Antimicrobial Resistance Research Use and Resistance Eligible Antimicrobial Agents |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Antimicrobial_Agent | Defined as select antimicrobial agents and stratified by route of administration (i.e., intravenous, intramuscular, digestive and respiratory). | string | required : 1maxLength : 30 |
Value | The drug values used for the development of the CDA files. "a" = RxNorm or NHSN Code. | string | required : 1maxLength : 7 |
NHSN_Drug_Code | The list of NHSN drug codes used for the development of the CDA files. | string | required : 1maxLength : 14 |
Antimicrobial_Category | It defines the antimicrobial categorically. | string | required : 1maxLength : 22 |
Antimicrobial_Class | Classification of Antimicrobial agents. "b" = Adapted from CLSI January 2014. | string | required : 1maxLength : 43 |
Antimicrobial_Subclass | Sub classification of Antimicrobial agents. "b" = Adapted from CLSI January 2014. | string | maxLength : 38 |
Data Preview
Antimicrobial Agent | Value | NHSN Drug Code | Antimicrobial Category | Antimicrobial Class | Antimicrobial Subclass |
AMANTADINE | 620 | AMAN | Anti-influenza | M2 ion channel inhibitors | |
AMIKACIN | 641 | AMK | Antibacterial | Aminoglycosides | |
AMIKACIN LIPOSOMAL | 2059180 | AMIKLIP | Antibacterial | Aminoglycosides | |
AMOXICILLIN | 723 | AMOX | Antibacterial | Penicillins | Aminopenicillin |
AMOXICILLIN/CLAVULANATE | 19711 | AMOXWC | Antibacterial | ?-lactam/ ?-lactamase inhibitor combination | |
AMPHOTERICIN B | 732 | AMPH | Antifungal | Polyenes | |
AMPHOTERICIN B LIPID COMPLEX | 2001759 | AMPBLIC | Antifungal | Polyenes | |
AMPHOTERICIN B LIPOSOMAL | 236594 | AMPHOT | Antifungal | Polyenes | |
AMPICILLIN | 733 | AMP | Antibacterial | Penicillins | Aminopenicillin |
AMPICILLIN/SULBACTAM | 1009148 | AMPIWS | Antibacterial | ?-lactam/ ?-lactamase inhibitor combination |